"By investing in enteral nutrition R&D India, we stand firm to our actions today as we build capabilities, empower teams and innovate with purpose, laying the foundation for a better tomorrow for patients across geographies." says Satish Kulkarni, EVP, Regional Business Centre, Region AP
Expanding the already established R&D Center in Gurugram strengthens its role within the Fresenius Kabi global Research and Development network. This expansion enables faster product development cycles and fosters deeper collaboration with global and local stakeholders. The Gurugram center is set to take on new projects from Q3 onwards to contribute to the global R&D network of Fresenius Kabi.
"By expanding our Enteral Nutrition R&D center in India, we are laying the foundation for the future of Fresenius Kabi’s nutrition research in the APAC region & beyond. By bringing our R&D centers closer to our markets, we can not only innovate faster but also ensure our products are relevant and deeply aligned with local health needs. This is a critical leap forward in our ambition to serve patients beyond expectations." says Sebastien Guery, Executive Vice-President Business Unit Nutrition
The center complements the R&D center in Wuxi, China and the R&D center at our Headquarters in Bad Homburg, Germany, that will open in 2026.
